The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon
Living Wage
Work 020 7400 8000
Fax 020 7400 8050

Dominic Adair

Work 020 7400 8365
Bristows LLP

Work Department

Intellectual property


Dominic trained with the firm and was made partner in 2014. He specialises in patent litigation. Dominic has a science background to PhD level (BA Natural Sciences and PhD Zoology, University of Cambridge) and this gives him an excellent grounding in the technical aspects of his cases, particularly in the life sciences sector. He has experience of proceedings before the UK Intellectual Property Office, High Court, Court of Appeal and of Opposition proceedings before the EPO in diverse technology ranging from pharmaceuticals to consumer goods.

He has extensive experience of cross-border litigation in and beyond Europe and in the pharmaceutical and biotechnology sector, Dominic has worked on all aspects of the drug life cycle, from freedom to operate analyses and early-stage risk assessment of generic competition to end-stage litigation, SPCs and anti-trust issues.

Dominic writes regularly on reported patent cases in the UK and at the EPO. He is a member of the European Patent Lawyers Association (EPLAW), an associate member of the Chartered Institute of Patent Attorneys and sits on the UK council of AIPPI, within which he chairs the Events Committee. He speaks regularly on recent developments in patent case law and practice.


Trained Bristows; qualified 2004; partner 2014.


University of Cambridge (MA Natural Sciences; PhD Zoology); University of Bristol (Diploma in Intellectual Property Law and Practice).


Rowing, running, cycling.

London: TMT (technology, media and telecoms)

Intellectual property

Within: Intellectual property

Bristows LLP  has been described as 'undoubtedly one of the leading IP firms' and attracts praise for its 'strong legal and technical expertise'. The group is highlighted by one client as the '‘go to’ firm for cost-effective patent litigation in all areas of technology', and was recently instructed by Varian in its global patent dispute with Elekta. Myles Jelf (who 'never fails to impress') led this matter and jointly heads the contentious patents team alongside the 'brilliant, calm and optimistic' Brian Cordery. In another work highlight, the 'exceptionally good' Dominic Adair led a team defending Edgewell Personal Care Company in allegations of patent infringement brought by Gillette. The department has also been instructed by ZTE in a dispute concerning patent infringement allegations and FRAND declarations. Beyond patent litigation, the team, instructed by Mondelez, successfully opposed NestlĂ©'s trademark application for the shape of the four finger KitKat in a matter headed by Jeremy Blum. The department is also instructed by other well-known brands such as Samsung, Philips, LVMH and Johnson & Johnson. Key names to note include head of commercial IP Matthew Warren and head of brands Paul Walsh. The firm's 'consistently excellent service' was further bolstered by the arrivals of Ian Gruselle and Simon Clark from Bryan Cave Leighton Paisner LLP; they head up the firm's dedicated trade mark portfolio and copyright practices respectively. Greg Bacon and Gemma Barrett were promoted to the partnership.

[back to top]

Pharmaceuticals and biotechnology

Within: Pharmaceuticals and biotechnology

The 'excellent' and 'client-focused' Bristows LLP has a strong reputation in patent litigation, but also works on matters involving transactions, regulations and competition. The practice is headed by patent litigator Liz Cohen and transactions specialist Laura Anderson. Brian Cordery is head of patent litigation and very active in this space. He was instructed by Teva in patent revocation proceedings brought by Eli Lilly relating to humanised antibodies, which may be used for a landmark treatment of migraines. Other important  contentious IP specialists include Edward Nodder, Robert Burrows and Dominic Adair. Burrows defended Janssen Sciences and G.D. Searle against a revocation brought by Sandoz and Hexal relating to darunavir, which is a key ingredient in Janssen's anti-HIV drug Prezista. Also recommended are corporate specialist Marek Petecki, who assisted AstraZeneca with its $300m sale of the European commercial rights to its Seloken heart medication to Recordati, and senior associate Rachel Mumby, who focuses on patent litigation.

[back to top]

Back to index

Legal Developments in London

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to